References
- Wilmink AB, Quick CR, Epidemiology and potential for prevention of abdominal aortic aneurysm. Br J Surg (1998) 85: 155–62.
- Guirguis EM, Barber GG, The natural history of abdominal aortic aneurysms. Am J Surg (1991) 162: 481–3.
- Collin J, Aortic aneurysms: aetiology and prevalence. In: Arterial aneurysms (ed M Horrocks). Butterworth-Heinemann Ltd, Oxford, 1995, 1–18.
- Curci JA, Liao S, Huffman MD, Shapiro SD, Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest (1998) 102: 1900–10.
- Mecham RP, Broekelmann TJ, Fliszar CJ, Shapiro SD, Elastin degradation by matrix metalloproteinases. Cleavage site specifity and mechanisms of elastolysis. J Biol Chem (1997) 272: 18071–6.
- Froon AHM, Greve JWM, Vanderlinden CJ, Buurman WA, Increased concentrations of cytokines and adhesion molecules in patients after repair of abdominal aortic aneurysm. Eur J Surg (1996) 162: 287–96.
- Patel MI, Hardman DTA, Fisher ChM, Appelberg M, Current views on the pathogenesis of abdominal aortic aneurysms. J Am CollSurg (1995) 181: 371–82.
- Halloran BG, Baxter BT, Pathogenesis of aneurysms. Sem Vasc Surg (1995) 8: 85–92.
- Wills A, Thompson MM, Crowether M, Sayers RD, Pathogenesis of abdominal aortic aneurysms – cellular and biochemical mechanisms. Eur J Vasc Endovasc Surg (1996) 12: 391–400.
- Rijbroek A, Moll FL, Dijk HA, Meijer R, Inflammation of the abdominal aortic aneurysm wall. Eur J Vasc Surg (1994) 8: 41–6.
- Brophy CM, Reilly JM, Smith GJ, Tilson MD, The role of inflammation in nonspecific abdominal aortic aneurysm disease. Ann Vasc Surg (1991) 5: 229–33.
- Rehm JP, Grange JJ, Baxter BT, The formation of aneurysm. Sem Vasc Surg (1998) 11: 193–202.
- Juvonen J, Surcel HM, Satta J, Teppo AM, Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (1997) 17: 2843–7.
- Freestone T, Turner RJ, Coady A, Higman DJ, Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (1995) 15: 1145–51.
- Watanabe T, Haraoka S, Shimokama T, Inflammatory and immunological nature of atherosclerosis. Int J Cardiol (1996) 54: S25–34.
- Jones KG, Brull DJ, Brown LC, Sian M, Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation (2001) 103: 2260–5.
- Rowlands TE, Homer-Vanniasinkam S, Pro-and anti-inflammatory cytokine release in open versus endovascular repair of abdominal aortic aneurysm. Br J Surg (2001) 88: 1335–40.
- Satta J, Soini Y, Pollanen R, Paakko P, Tenascin expression is associated with a chronic inflammatory process in abdominal aortic aneurysms. J Vasc Surg (1997) 26: 670–5.
- Szekanecz Z, Shah MR, Pearce WH, Koch AE, Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-gamma in vascular inflammation. Agents Actions (1994) 42: 159–62.
- Kocova J, Histopathology of abdominal aortic aneurysm. In: Abdominal Aortic Aneurysm (ed V Treska). Grada Publishing, Prague, 1999, 18–26.
- Zarins Kch, Seymour G, Artery wall pathology in atherosclerosis. In: Vascular Surgery (ed RB Rutherford). WB Saunders, Philadelphia, 1995, 204–11.
- Grange JJ, Davis V, Baxter BT, Pathogenesis of abdominal aortic aneurysm: an update and look toward the future. Cardiovasc Surg (1997) 5: 256–66.
- Kocova J, Treska V, Valenta J, Reischig J, Microscopical structure of aortic aneurysms. Anatom Anz (1997) 179: S256.
- Thompson MM, Jones L, Nasim A, Sayers RD, Angiogenesis in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg (1996) 11: 464–9.
- Satta J, Soini Y, Mosorin M, Juvonen T, Angiogenesis is associated with mononuclear inflammatory cells in abdominal aortic aneurysms. Ann Chir Gynecol (1998) 87: 40–2.
- Holmes DR, Liao S, Parks WC, Thompson RW, Medial neovascularisation in abdominal aortic aneurysms: a histopathologic marker of aneurysmal degeneration with pathophasiologic implications. J Vasc Surg (1995) 21: 761–71.
- Ross R, The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (1993) 362: 801–9.
- Hingorani A, Ascher E, Scheinman M, Yorkovich W, The effect of tumor necrosis factor binding protein and interleukin-1 receptor antagonist on the development of abdominal aortic aneurysms in a rat model. J Vasc Surg (1998) 28: 522–6.
- Davis VA, Persidskaia RN, Baca-Regen LM, Fiotti N, Cytokine pattern in aneurysmal and occlusive disease of the aorta. J Surg Res (2001) 101: 152–6.
- Lepidi S, Kenagy RD, Raines EW, Chiu ES, MMP9 production by human monocyte-derived macrophages is decreased on polymerized type I collagen. J Vasc Surg (2001) 34: 1111–8.
- Treska V, Topolcan O, Wenham PW, Pecen L, Metabolism of cytokines in abdominal aortic aneurysms. Rozhl chir (1998) 77: 225–9.
- Marian AJ, On genetics, inflammation, and abdominal aortic aneurysm: can single nucleotide polymorphisms predict the outcome? Circulation (2001) 103: 2222–4.
- Henderson EL, Geng YJ, Sukhova GK, Whittemore AD, Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation (1999) 99: 96–104.
- Lopez-Candales A, Holmes D, Liao S, Scott M, Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol (1997) 150: 993–1007.
- Allaire E, Forough R, Clowes M, Starcher B, Local over expression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. Clin Invest (1998) 102: 1413–20.
- Brophy CM, Tilson JE, Broserman IM, Tilson MD, Age of onset, pattern of distribution, and histology of aneurysm development in a genetically predisposed mouse model. J Vasc Surg (1988) 8: 45–8.
- Swartbol P, Truedsson L, Norgren L, Adverse reactions during endovascular treatment of aortic aneurysms may be triggered by interleukin 6 release from the thrombotic content. J Vasc Surg (1998) 28: 664–8.
- Parodi JC, Ferreira LM, Fornari MC, Berardi VE, Neutrophil respiratory burst activity and pro- and anti-inflammatory cytokines in AAA surgery: conventional versus endoluminal treatment. J Endovasc Ther (2001) 8: 114–24.
- Svoboda P, Kantorova I, Ochmann J, Dynamics of interleukin 1, 2, and 6 and tumor necrosis factor alpha in multiple trauma patients. J Trauma (1996) 36: 336–40.
- Pearce WH, Sweis I, Yao JST, Interleukin-1β and tumor necrosis factor-a release in normal and diseased human infrarenal aortas. J Vasc Surg (1992) 16: 784–9.
- Franklin IJ, Walton LJ, Greenhalgh RM, Powell JT, The influence of indomethacin on the metabolism and cytokine secretion of human aneurysmal aorta. Eur J Vasc Endovasc Surg (1999) 18: 35–42.
- Franklin IJ, Harley SL, Greenhalgh RM, Powell JT, Uptake of tetracycline by aortic aneurysm wall and its effect on inflammation and proteolysis. Br J Surg (1999) 86: 771–5.